Why Contraceptive Innovation?

Despite the availability of various contraceptive methods, more than 200 million women in developing countries want to avoid or delay pregnancy yet are not using an effective family planning method. For some of these women, access to contraception is limited. For others, currently available methods do not meet their needs or preferences or are unaffordable. Innovative solutions are needed in the areas of product development, registration, pricing, and introduction to address these barriers.

Join the exchange and become part of the solution!

Visit our resource library for additional information about the need for contraceptive innovation.


A one-stop shop for resources related to contraceptive research and development

The CTI Exchange offers resources about contraceptive research and development, including information about products currently in development, preclinical and clinical research, and opportunities for future investment. This easily searchable resource library also includes information about regulatory requirements, quality assurance standards, intellectual property, and product introduction strategies, as well as tools for advocacy.

View all resources


Latest news, events, resources, and thought pieces from the Exchange's blog


Contraceptive Research Opportunity for Small Businesses
NICHD has issued a Small Business Innovation Research funding solicitation to support/facilitate development of new or improved contraceptive products for men and women. 

Key Conference Abstract Deadlines Approaching
Calls for abstracts and panels have been announced for three upcoming conferences of interest to contraceptive researchers.

Empowering Women Who Want to "Stick" with Contraception
Self-injection of DMPA-SC is emerging as a key way to help women keep using the method for as long as they wish.

Family Planning Global Handbook Updated
The 2018 edition of “Family Planning: A Global Handbook for Providers” provides up-to-date family planning guidance for health care professionals working in low- and middle-income countr...

Contraceptive Implant Strategic Partnership Announced
DKT International and Shanghai Dahua Pharmaceutical have entered into a strategic partnership to expand the availability, accessibility, and affordability of the contraceptive implant, Levo...

The Buzz about Microneedle Patches
Microneedles are being evaluated for diagnostic purposes and to deliver drugs, vaccines, and biotherapeutics. Could they also deliver contraceptives?

Overcoming Regulatory Barriers to Increase Female Condom Access
One small rule change being considered by the U.S. Food and Drug Administration could expand internal condom options available to women, men, and young people.

When Developing New Contraceptives, Begin with the End in Mind
What needs to be done at the outset of contraceptive product development research to ensure final products are acceptable, affordable and accessible?

Building the Case for Contraceptive Technology Innovati...
What are we, who work in contraceptive technology research, doing to fill remaining gaps in the method mix?  Clearly not enough…and clearly not fast enough!

FDA Proposes Female Condom Rule Change
The U.S. Food and Drug Administration proposes to reclassify and rename the single-use female condom, given the expansion of its indications for use by diverse populations with diverse needs...

FDA to Review One-year Vaginal Ring
The U.S. Food and Drug Administration has accepted for review a contraceptive vaginal ring that would be the first contraceptive fully under a woman’s control to provide one year of pregna...

Introducing CAPRI, the Contraceptive API Database
CAPRI, the Contraceptive Active Pharmaceutical Ingredient Database, contains information on the physical and chemical properties of five estrogens, 21 progestins, and one selective progester...

Featured Resources

Other key resources related to contraceptive research and development

Calliope, the Contraceptive Pipeline Database, includes information on potential contraceptive targets and leads, products in development, and a selection of products only available in limited markets.
CAPRI, the Contraceptive Active Pharmaceutical Ingredient Database, lists biological and chemical properties for 27 active pharmaceutical ingredients found in contraceptives, along with data on their pharmacology, toxicology, impurities, metabolites, and use in marketed products.


We want you to join the exchange!

The CTI Exchange looks to partners to help generate and share resources. Contact us with your ideas, materials, or questions, or sign up to receive more information. We also encourage you to provide your feedback